Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Breast Neoplasms × Diffusion Tensor Imaging × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 180 Paclitaxel 161 Fulvestrant 136 Capecitabine 128 Docetaxel 118 Letrozole 108 exemestane 75 Lapatinib 65 Anastrozole 62 palbociclib 60 Cyclophosphamide 60 Bevacizumab 56 Gemcitabine 55 pertuzumab 53 pembrolizumab 49 Carboplatin 47 ribociclib 46 abemaciclib 45 eribulin 41 Doxorubicin 36 Vinorelbine 35 Ado-Trastuzumab Emtansine 35 Tamoxifen 32 Everolimus 31 130-nm albumin-bound paclitaxel 29 Injections 28 trastuzumab deruxtecan 26 Albumin-Bound Paclitaxel 24 Goserelin 21 pegfilgrastim 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01910298 2019-12-04

ESSBR

LifeCell

Phase NA Terminated

131 enrolled 14 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡